Screener
Disc Medicine IRON Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 100,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 38,190,464 and 37,890,616 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 4 | 4 |
| Additional paid-in capital | 1,262,686 | 1,249,043 |
| Accumulated other comprehensive (loss) income | (571) | 965 |
| Accumulated deficit | (573,690) | (510,186) |
| Total stockholders’ equity | 688,429 | 739,826 |
| Total liabilities and stockholders’ equity | $750,213 | $806,879 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's total equity?
- Disc Medicine (IRON) reported total equity of $688.43M in Q1 2026.
- How has Disc Medicine's total equity changed year-over-year?
- Disc Medicine's total equity increased by 4.3% year-over-year, from $660.36M to $688.43M.
- What is the long-term trend for Disc Medicine's total equity?
- Over 5 years (2020 to 2025), Disc Medicine's total equity has grown at a 91.4% compound annual growth rate (CAGR), from -$28.81M to $739.83M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Disc Medicine's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude